共 112 条
[1]
Mourad G(2004)Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids Transplantation 78 584-1805
[2]
Rostaing L(2005)Long-term evaluation of basiliximab induction therapy in live donor kidney transplantation: a 5-year prospective randomized study Am J Nephrol 25 221-undefined
[3]
Legendre C(2005)Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens: a comparative review BioDrugs Clin Immunother Biopharm Gene Ther 19 39-undefined
[4]
Garrigue V(2005)Multivariate analysis of antibody induction therapy and their associated outcomes in deceased donor transplants Transpl Proc 37 889-undefined
[5]
Thervet E(2014)The impact of induction therapy on the homeostasis and function of regulatory T cells in kidney transplant patients Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Ren Assoc 29 1587-undefined
[6]
Durand D(2013)In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development J Immunol 191 2818-undefined
[7]
Sheashaa HA(2012)Impact of basiliximab on the proportion of regulatory T cells and their subsets early after renal transplantation: a preliminary report Transpl Proc 44 175-undefined
[8]
Bakr MA(2001)Bringing it all together: Lancet-Cochrane collaborate on systematic reviews Lancet 357 1728-undefined
[9]
Ismail AM(2000)Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group JAMA 283 2008-undefined
[10]
Gheith OE(1986)Meta-analysis in clinical trials Control Clin Trials 7 177-undefined